This analysis demonstrated the reliability of the PD-L1 (SP263) assay to determine the PD-L1 expression of NSCLC and HNSCC tumor samples obtained in a clinical setting based on a ≥25 % cut-off value for positively stained tumor cells. Here, CD274 is linked to non-small cell lung carcinoma.